UAE Equity Research - Investcorp Capital PLC (ICAP) 2Q26 - First Look Note
Effective annualized yield of CFS and CD segments stood at 10% and 7%, respectively in 1H26. Investment activity across both underwriting (CFS) and co-investment (CD) segments reached USD 614 Mn in 1H26 compared to USD 480 Mn in 1H25, reflecting continued deployment across private equity, global credit and real assets.
UAE Equity Research - Investcorp Capital PLC (ICAP) 2Q26 - Earnings call insight
Net profit declined 6.3% YOY to USD 15 Mn in 2Q26, in line with our estimates. The decline was impacted by higher finance cost, however partially offset expansion in gross operating income.
UAE Equity Research - Investcorp Capital PLC (ICAP) 1Q26 - First Look Note
Effective annualized yield of CFS and CD Segment stood at 11% and 7%, respectively in 1Q26. Investment across both CFS and CD segments stood at USD 88 Mn in 1Q26 compared to USD 104 Mn in 1Q25 as several transactions remain under process and expected to be completed in 2Q26.
UAE Equity Research - Investcorp Capital PLC (ICAP) - 4Q25 First Look Note
The Company’s profitability was impacted in 2025 by higher interest expenses due to increased utilisation of the revolving credit facility (RCF). Corporate Investments exposure reached USD 630 Mn in 4Q25, representing 48% of total deployment, diversified across North America, Europe, Asia, and MENA/Turkey, with insurance and industrial sectors as the largest investment allocations.
UAE Equity Research - Investcorp Capital PLC (ICAP) 3Q25 - First Look Note
Investcorp Capital Plc’s net profit fell 13.3% YOY to USD 13 Mn in 3Q25. As of 3Q25, the carrying value of the Company's capital deployment exposure in Corporate Investments stood at USD 591 Mn, representing 47% of the total capital deployment exposures.
UAE Equity Research - Investcorp Capital PLC (ICAP) 2Q25 - First Look Note
Investcorp Capital Plc’s net profit fell 23.8% YOY to USD 16 Mn in 2Q25. As of 2Q25, the carrying value of the Company's capital deployment exposure in Corporate Investments stood at USD 569 Mn, representing 58% of the total capital deployment exposures. CFS activities grew significantly, with deployment increasing from USD 90 Mn in 1Q25 to USD 405 Mn in 1H25.
1.47
